fulvestrant has been researched along with Prostatitis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bernoulli, J; Lammintausta, R; Santti, R; Yatkin, E | 1 |
Bernoulli, J; Santti, R; Streng, T; Talvitie, EM; Yatkin, E | 1 |
2 other study(ies) available for fulvestrant and Prostatitis
Article | Year |
---|---|
Fispemifene [Z-2-{2-[4-(4-chloro-1,2-diphenylbut-1-enyl)-phenoxy]ethoxy}-ethanol], a novel selective estrogen receptor modulator, attenuates glandular inflammation in an animal model of chronic nonbacterial prostatitis.
Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Estradiol; Estrogen Antagonists; Fos-Related Antigen-2; Fulvestrant; Immunohistochemistry; Male; Organ Size; Prolactin; Prostatitis; Rats; Receptors, Progesterone; Selective Estrogen Receptor Modulators; Tamoxifen; Testosterone | 2008 |
Urodynamic changes in a noble rat model for nonbacterial prostatic inflammation.
Topics: Animals; Electromyography; Estradiol; Estrogen Antagonists; Fulvestrant; Histocytochemistry; Male; Organ Size; Prostatitis; Rats; Statistics, Nonparametric; Testosterone; Urinary Bladder; Urination Disorders | 2007 |